《半日速報》恆指半日收報21,730點 跌129點; 恆生科技指數半日收報4,849點 跌20點 港交所跌逾3% 建發國際集團創新高
恆指半日收21,730點,跌129點或0.6%。恆生科技指數報4,849點,跌20點或0.4%。國指跌44點或0.6%,報7,621點。
活躍重磅股表現:
港交所(00388.HK) 收371.6元,下跌3.7%;
美團(03690.HK) 收199.7元,上升2.8%;
騰訊(00700.HK) 收350.4元,下跌1.1%;
阿里巴巴(09988.HK) 收112.9元,上升0.9%;
友邦(01299.HK) 收84.4元,下跌0.8%;
異動恆指及國指成份股:
信達生物(01801.HK) 收38.1元,上升9.2%;
舜宇(02382.HK) 收119.7元,下跌6.4%;
中生製藥(01177.HK) 收5.24元,上升5.4%;
中國飛鶴(06186.HK) 收8.57元,下跌5%;
藥明生物(02269.HK) 收75.1元,上升4.6%;
申洲(02313.HK) 收91.15元,下跌4.1%;
九龍倉置業(01997.HK) 收35.95元,下跌3.9%;
碧桂園服務(06098.HK) 收33.6元,下跌3.9%;
華潤啤酒(00291.HK) 收56.25元,下跌3.8%;
中國宏橋(01378.HK) 收8.53元,下跌3.8%;
吉利(00175.HK) 收17.18元,下跌3.7%;
京東健康(06618.HK) 收63.4元,上升3%;
異動綜合中小型股:
百富環球(00327.HK) 收7.33元,上升20%;
微創機器人-B(02252.HK) 收36.25元,上升16.6%;
正商實業(00185.HK) 收2.59元,下跌16.5%;
融信中國(03301.HK) 收1.64元,下跌15.9%;
再鼎醫藥-B(09688.HK) 收30.55元,上升14.2%;
澳優(01717.HK) 收7.27元,下跌12.2%;
融創服務(01516.HK) 收4.23元,下跌11.3%;
康方生物(09926.HK) 收25.65元,上升11.3%;
和黃醫藥(00013.HK) 收21.5元,上升11.2%;
建發國際集團(01908.HK) 收22.8元,上升7.5%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.